HomeAgendaEU support offersContact
Register
Register
Register

Project cooperationUpdated on 16 February 2026

CUTIVAX

Head of Project & IP Management at Bogazici University Center for Targeted Therapy Technologies

İstanbul, Türkiye

About

CUTIVAX PLATFORM

Tumor tissue collected during surgery or biopsy.

Cells inactivated with Far-UVC turn into immunogenic “ghosts”.

Implanted subcutaneously or in a surgical lodge near lymphatic regions.

Immune cells infiltrate & trigger local and systemic immunity.

Organisation

Similar opportunities